About us
Story
Team
Our Approach
Careers
News
Contact
Investor Relations
PL
EN
Home
Investor Relations Captor Therapeutics
Reports
Current reports
Captor Therapeutics
®
Investor Relations
Menu
Investor Relations
Company
Company
Management Board
Supervisory Board
General Meeting (PL)
Corporate documents
Reports
Current reports
Periodic reports
EBI reports
Financial Highlights
Shares and Shareholders
Stock Chart
Shareholders
Incentive Scheme
Other information
IPO (PL)
Presentations
Contact
Investor Relations Menu
Company
Company
Management Board
Supervisory Board
General Meeting (PL)
Corporate documents
Reports
Current reports
Periodic reports
EBI reports
Financial Highlights
Shares and Shareholders
Stock Chart
Shareholders
Incentive Scheme
Other information
IPO (PL)
Presentations
Contact
Investor Relations
Current reports
2022
2021
RB ESPI 12/2022 /
Progress in research and development related to CT-01 project
Publication date: 2022-04-19
RB ESPI 1/2022 /
Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-01-05
RB ESPI 2/2022 /
Appointment of a member of the Company's Supervisory Board
Publication date: 2022-01-05
RB ESPI 3/2022 /
Progress in research and development related to CT-01 project
Publication date: 2022-01-11
RB ESPI 4/2022 /
Announcement of convening Extraordinary General Meeting together with draft resolutions
Publication date: 2022-01-25
RB ESPI 5/2022 /
Filing by the Company of notification to NCBiR regarding potential irregularities in settlement of eligible costs in EU projects
Publication date: 2022-01-26
RB ESPI 6/2022 /
Dates of publication of periodic reports in 2022
Publication date: 2022-01-26
RB ESPI 7/2022 /
Text of resolutions adopted by the Extraordinary General Meeting on 21 February 2021
Publication date: 2022-02-21
RB ESPI 8/2022 /
List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 21 February 2022
Publication date: 2022-02-21
RB ESPI 9/2022 /
Progress in research and development related to CT-03 project
Publication date: 2022-02-24
RB ESPI 10/2022 /
Information on receipt by the Company of the results of the Audit
Publication date: 2022-04-08
RB ESPI 11/2022 /
Disclosure of molecular targets in CT-01 project
Publication date: 2022-04-11
RB ESPI 13/2022 /
Adoption of a resolution by the Company's Management Board concerning the issuance of shares as part of an authorized share capital increase
Publication date: 2022-04-27
RB ESPI 14/2022 /
Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-05-05
RB ESPI 15/2022 /
Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-05-05
RB ESPI 16/2022 /
Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-05-05
RB ESPI 17/2022 /
Registration of share capital increase and amendments to the Company's Articles of Association
Publication date: 2022-05-12
RB ESPI 18/2022 /
Change of the publication date of the extended consolidated quarterly report for Q1 2022
Publication date: 2022-05-20
RB ESPI 19/2022 /
Potential delays to the Company's project
Publication date: 2022-05-27
RB ESPI 20/2022 /
Notice of convocation of the Ordinary General Shareholders Meeting and draft resolutions of the Ordinary General Shareholders Meeting
Publication date: 2022-06-03
RB ESPI 21/2022 /
Submitting Candidates for Members of the Supervisory Board of the Company
Publication date: 2022-06-10
RB ESPI 22/2022 /
Completion of subscription of series K shares issued in connection with the implementation of the Company's employee incentive scheme
Publication date: 2022-06-15
RB ESPI 23/2022 /
Announcement of the Central Securities Depository of Poland on the conditional registration of series K ordinary bearer shares
Publication date: 2022-06-28
RB EBI 24/2022 /
Admission and introduction to exchange trading of series K ordinary bearer shares
Publication date: 2022-06-29
RB ESPI 25/2022 /
Announcement of a break in the Ordinary General Meeting of Captor Therapeutics S.A. on 30 June 2022 and the content of the resolutions adopted until the break
Publication date: 2022-06-30
RB ESPI 26/2022 /
Announcement of the National Securities Depository S.A. on the registration of series K ordinary bearer shares in the securities depository
Publication date: 2022-06-30
RB ESPI 27/2022 /
Appointment of the Company's Supervisory Board, Management Board, Audit Committee and Remuneration Committee for the next term
Publication date: 2022-06-30
RB ESPI 30/2021 /
Notification of increase in shareholding
Publication date: 2021-10-15
RB ESPI 31/2021 /
Notification of increase in shareholding
Publication date: 2021-10-26
RB ESPI 32/2021 /
Adoption of a resolution by the Company's Management Board concerning the issuance of shares as part of an authorized share capital increase
Publication date: 2021-12-13
RB ESPI 33/2021 /
Resignation of a member of the Company's Supervisory Board
Publication date: 2021-12-14
RB ESPI 29/2021 /
Registration of amendments to the Company's Articles of Association
Publication date: 2021-10-14
RB ESPI 28/2021 /
The Company purchased specialized laboratory equipment
Publication date: 2021-09-29
RB ESPI 27/2021 /
Progress in research and development related to CT-3 project and disclosure of molecular target in CT-3 project
Publication date: 2021-09-28
RB ESPI 26/2021 /
Conclusion of a service agreement concerning, among others, investor relations
Publication date: 2021-08-30
RB ESPI 25/2021 /
Zakończenie subskrypcji akcji serii G oraz sprzedaży części akcji serii B w ofercie publicznej – uzupełnienie raportu bieżącego nr 4/2021 z 15 kwietnia 2021 r.
Publication date: 2021-07-30
RB ESPI 24/2021 /
Appointment of an audit firm (extension of an audit agreement)
Publication date: 2021-07-22
RB ESPI 23/2021 /
Information on a transaction in shares of the Company obtained pursuant to Article 19 of MAR
Publication date: 2021-07-02
RB ESPI 22/2021 /
Notice of reduction of shareholding interest in Company
Publication date: 2021-07-02
RB ESPI 21/2021 /
List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 29 June 2021
Publication date: 2021-06-30
RB ESPI 20/2021 /
Text of resolutions adopted by the Ordinary General Meeting on 29 June 2021
Publication date: 2021-06-29
RB ESPI 19/2021 /
Appointment of a member of the Company's Management Board and the Chief Financial Officer
Publication date: 2021-06-29
RB ESPI 18/2021 /
Resignation of a member of the Company's Management Board
Publication date: 2021-06-21
RB ESPI 17/2021 /
Announcement of KDPW on registration of G series shares in securities depository
Publication date: 2021-06-09
RB ESPI 16/2021 /
Designation of the last day of listing of the rights to G series shares and introduction of G series shares to exchange trading
Publication date: 2021-06-09
RB ESPI 15/2021 /
A shareholder’s request to include certain matters on the agenda of the Ordinary General Meeting called for 29 June 2021
Publication date: 2021-06-08
RB ESPI 14/2021 /
Notice of convocation of the Ordinary General Shareholders Meeting and draft resolutions of the Ordinary General Shareholders Meeting
Publication date: 2021-06-02
RB ESPI 13/2021 /
Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28
RB ESPI 12/2021 /
Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28
RB ESPI 11/2021 /
Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28
RB ESPI 10/2021 /
Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28
RB ESPI 9/2021 /
Notice of reduction of shareholding interest in the Company
Publication date: 2021-05-28
RB ESPI 8/2021 /
Registration of the increase of the share capital through the issuance of G series shares
Publication date: 2021-05-24
RB ESPI 7/2021 /
Dates of publication of interim reports
Publication date: 2021-04-27
RB ESPI 6/2021 /
Introduction of shares and rights to shares to trading on a regulated market
Publication date: 2021-04-16
RB ESPI 5/2020 /
KDPW announcements on registration of shares and rights to shares in the securities depository
Publication date: 2021-04-15
RB ESPI 4/2021 /
Closing of the subscription of G series shares and sale of a part of B series shares in a public offering
Publication date: 2021-04-15
RB ESPI 3/2021 /
Admission of shares and rights to shares to trading
Publication date: 2021-04-15
RB ESPI 2/2021 /
Registration of outstanding shares and rights to shares in KDPW
Publication date: 2021-04-15
RB ESPI 1/2021 /
Granting of access to the Electronic Reporting System (“ERS”)
Publication date: 2021-04-15